Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Tłumaczenie nie jest jeszcze gotowe. Wyświetlamy oryginalny artykuł.

Prediction market event contracts on both clinical drug trials and Food and Drug Administration regulatory approvals are drawing attention from two Democratic senators, according to a letter obtained first by CNBC. Sen. Angela Alsobrooks , D-Md., and Sen. Ron Wyden , D-Ore., expressed concern over the related event contracts in a Wednesday letter to Department of Health and Human Services Secretary Robert F. Kennedy Jr . The senators asked what measures HHS has taken to mitigate any risks that may arise from the markets.